Literature DB >> 31586893

Leading edge or tumor core: Intratumor cancer stem cell niches in oral cavity squamous cell carcinoma and their association with stem cell function.

Farshad N Chowdhury1, Julie Reisinger2, Karina E Gomez2, Tugs-Saikhan Chimed2, Carissa M Thomas3, Phuong N Le2, Bettina Miller2, John J Morton2, Cera M Nieto2, Hilary L Somerset4, Xiao-Jing Wang4, Stephen B Keysar5, Antonio Jimeno6.   

Abstract

OBJECTIVES: To describe differences in cancer stem cell (CSC) presence and behavior associated with their intratumor compartment of origin using a patient-derived xenograft (PDX) model of oral cavity squamous cell carcinoma (OCSCC).
MATERIALS AND METHODS: Four HPV-negative OCSCC PDX cases were selected (CUHN004, CUHN013, CUHN096, CUHN111) and the percentage of CSCs (ALDH+CD44high) was measured in the tumor Leading Edge (LE) and Core compartments of each PDX tumor case via fluorescence activated cell sorting (FACS). The fraction of cells in the proliferative phase was measured by Ki-67 labelling index of paraffin embedded tissue. The proliferation and invasion of LE versus Core CSCs were compared using sphere and Matrigel invasion assays, respectively.
RESULTS: Both CUHN111 and CUHN004 demonstrate CSC enrichment in their LE compartments while CUHN013 and CUHN096 show no intratumor difference. Cases with LE CSC enrichment demonstrate greater Ki-67 labelling at the LE. CSC proliferative potential, assessed by sphere formation, reveals greater sphere formation in CUHN111 LE CSCs, but no difference between CUHN013 LE and Core CSCs. CUHN111 CSCs do not demonstrate an intratumor difference in invasiveness while CUHN013 LE CSCs are more invasive than Core CSCs.
CONCLUSION: A discrete intratumor CSC niche is present in a subset of OCSCC PDX tumors. The CSC functional phenotype with regard to proliferation and invasion is associated with the intratumor compartment of origin of the CSC: LE or Core. These individual functional characteristics appear to be modulated independently of one another and independently of the presence of an intratumor CSC niche.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer stem cells; Head and neck neoplasms; Local neoplasm recurrence; Neoplasm invasion; Oral cancer; Stem cell niche; Surgical margins; Tumor microenvironment

Year:  2019        PMID: 31586893      PMCID: PMC6948018          DOI: 10.1016/j.oraloncology.2019.09.011

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  37 in total

Review 1.  Tumor microenvironment for cancer stem cells.

Authors:  Kazuyoshi Kise; Yumi Kinugasa-Katayama; Nobuyuki Takakura
Journal:  Adv Drug Deliv Rev       Date:  2015-09-08       Impact factor: 15.470

2.  Cancer statistics, 2018.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-01-04       Impact factor: 508.702

3.  Loss of SOX2 expression induces cell motility via vimentin up-regulation and is an unfavorable risk factor for survival of head and neck squamous cell carcinoma.

Authors:  Pilar Bayo; Adriana Jou; Albrecht Stenzinger; Chunxuan Shao; Madeleine Gross; Alexandra Jensen; Niels Grabe; Christel Herold Mende; Pantelis Varvaki Rados; Juergen Debus; Wilko Weichert; Peter K Plinkert; Peter Lichter; Kolja Freier; Jochen Hess
Journal:  Mol Oncol       Date:  2015-05-20       Impact factor: 6.603

Review 4.  SOX2 as prognostic factor in head and neck cancer: a systematic review and meta-analysis.

Authors:  Weimin Li; Baoping Li; Rongguang Wang; Dongyan Huang; Wei Jin; Shiming Yang
Journal:  Acta Otolaryngol       Date:  2014-11       Impact factor: 1.494

5.  Surgical margins in the genomic era: The Hayes Martin Lecture, 2012.

Authors:  Gregory T Wolf
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2012-11

6.  Infiltrating CD57+ inflammatory cells in head and neck squamous cell carcinoma: clinicopathological analysis and prognostic significance.

Authors:  Carlos Alberto de Carvalho Fraga; Marcos Vinícius Macedo de Oliveira; Patrícia Luciana Batista Domingos; Ana Cristina de Carvalho Botelho; André Luiz Sena Guimarães; Andréa Teixeira-Carvalho; Rodrigo Correa-Oliveira; Alfredo Maurício Batista De Paula
Journal:  Appl Immunohistochem Mol Morphol       Date:  2012-05

7.  Cancer statistics, 2015.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-01-05       Impact factor: 508.702

Review 8.  More than markers: biological significance of cancer stem cell-defining molecules.

Authors:  Stephen B Keysar; Antonio Jimeno
Journal:  Mol Cancer Ther       Date:  2010-08-17       Impact factor: 6.261

Review 9.  Emerging from their burrow: Hedgehog pathway inhibitors for cancer.

Authors:  Gregory N Gan; Antonio Jimeno
Journal:  Expert Opin Investig Drugs       Date:  2016-08-05       Impact factor: 6.206

Review 10.  Intra-tumor heterogeneity from a cancer stem cell perspective.

Authors:  Pramudita R Prasetyanti; Jan Paul Medema
Journal:  Mol Cancer       Date:  2017-02-16       Impact factor: 27.401

View more
  3 in total

1.  Cancer Cell CD44 Mediates Macrophage/Monocyte-Driven Regulation of Head and Neck Cancer Stem Cells.

Authors:  Karina E Gomez; FangLong Wu; Stephen B Keysar; J Jason Morton; Bettina Miller; Tugs-Saikhan Chimed; Phuong N Le; Cera Nieto; Farshad N Chowdhury; Anit Tyagi; Traci R Lyons; Christian D Young; Hongmei Zhou; Hilary L Somerset; Xiao-Jing Wang; Antonio Jimeno
Journal:  Cancer Res       Date:  2020-08-14       Impact factor: 12.701

2.  Identification of cancer stem cell characteristics in liver hepatocellular carcinoma by WGCNA analysis of transcriptome stemness index.

Authors:  Kun-Hao Bai; Si-Yuan He; Ling-Ling Shu; Wei-Da Wang; Shi-Yong Lin; Qian-Yi Zhang; Liang Li; Lei Cheng; Yu-Jun Dai
Journal:  Cancer Med       Date:  2020-04-20       Impact factor: 4.452

3.  A Mathematical Model of Average Dynamics in a Stem Cell Hierarchy Suggests the Combinatorial Targeting of Cancer Stem Cells and Progenitor Cells as a Potential Strategy against Tumor Growth.

Authors:  Rodolfo Molina-Peña; Juan Carlos Tudon-Martinez; Osvaldo Aquines-Gutiérrez
Journal:  Cancers (Basel)       Date:  2020-09-11       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.